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Protein folding poses unique challenges for large, disordered
proteins due to the low resolution of structural data accessible
in experiment and on the basis of short time scales and limited
sampling attainable in computation. Such molecules are uniquely
suited to accelerated-sampling molecular dynamics algorithms due
to a flat-energy landscape. We apply these methods to report here
the folded structure in water from a fully extended chain of
tropoelastin, a 698-amino acid molecular precursor to elastic fibers
that confer elasticity and recoil to tissues, finding good agreement
with experimental data. We then study a series of artificial and
disease-related mutations, yielding molecular mechanisms to
explain structural differences and variation in hierarchical assem-
bly observed in experiment. The present model builds a frame-
work for studying assembly and disease and yields critical insight
into molecular mechanisms behind these processes. These results
suggest that proteins with disordered regions are suitable candi-
dates for characterization by this approach.
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Protein folding remains an outstanding challenge for experi-ment and simulation, in particular for large, highly dynamic,
and largely disordered molecular systems. Proteins with a high
degree of disorder represent >30% of all proteins in eukaryotic
cells (1) and play important functions, from cell signaling and
membrane transport to protein folding and macromolecular as-
sembly processes, including misfolding and toxic aggregation in
disease (2, 3). An absence of tools to predict fully atomistic
structure for this class of proteins therefore presents a significant
obstacle for probing their function (4).
Molecular dynamics (MD) simulations have supplemented
experimental approaches such as X-ray crystallography. How-
ever, ab initio protein folding via MD has been achieved only for
small molecules, where folding times may be on the order of
microseconds, and is becoming more accessible to MD methods
through an increase in computing capabilities via massive par-
allelism and graphics processing unit (GPU) computing (4).
Large proteins beyond the length of short peptides remain elu-
sive, because folding time scales are on the order of seconds,
inaccessible to MD methods.
The main obstacle of traditional MD is ergodicity, stemming
from the challenge of describing a system with a vast number of
degrees of freedom that results in a complex free-energy land-
scape. MD methods, and even accelerated-sampling algorithms
based on collective variable biasing, temperature acceleration,
and tempering have not successfully reproduced ab initio protein
folding for systems with hundreds of amino acid residues. We
hypothesized that the dynamic nature and flat-energy landscape
of largely disordered proteins would render them amenable to
folding via accelerated-sampling MD (5). We show here that
replica exchange MD (REMD) can be used to fold a 698-residue
tropoelastin protein, validate the structure by comparison with
experimental data, and use it to study protein functionality and
disease etiology associated with mutations in the ELN gene.
Tropoelastin is the precursor molecule of elastin, which, to-
gether with microfibrils, forms elastic fibers, an essential com-
ponent of the extracellular matrix. Elastic fibers provide elasticity
and resilience to vertebrate tissues, in particular the skin, lungs,
and connective and vascular tissue (6, 7). The tropoelastin protein
is encoded by a single gene, ELN, with 34 exons, giving rise to a
mature molecular structure with a molecular weight of ∼60 kDa
(7). Within the tropoelastin sequence, hydrophobic domains rich
in repetitive motifs of glycine, valine, and proline residues are
arranged between hydrophilic, cross-linking domains rich in lysine
and alanine or proline residues. Tropoelastin is the most elastic
and distensible monomer protein known, extending to eight times
its length (8). After unraveling fully, tropoelastin recoils back
without hysteresis (8, 9). Its elasticity, although reduced upon
cross-linking and assembly, is propagated within elastic fibers that
can withstand a lifetime of extension and relaxation cycles (6).
Beyond its remarkable mechanical properties, tropoelastin and
elastin degradation products interact with cell-surface receptors
and stimulate cell responses, including chemotaxis, adhesion, and
proliferation (10). Elastin’s biocompatibility, coupled with its re-
sponsiveness to external triggers (11), has inspired its use in bio-
medical applications, such as drug delivery (12–14) and tissue
engineering (15). On the other hand, mutations in the elastin gene
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are associated with debilitating diseases such as cutis laxa and
supravalvular aortic stenosis (16).
The structure of tropoelastin has been the subject of decades of
research, constrained by the difficulty of isolating the monomer due
to extensive cross-links (7). As a result, many studies focused instead
on recombinant tropoelastin fragments, soluble elastin, and elastin-
like peptides (17–23). The expression of recombinant human full-
length tropoelastin allowed probing of its complete molecular
structure (8, 24). Recent small-angle X-ray scattering studies de-
termined the global molecular shape of tropoelastin to be an
asymmetric molecule, with an extended, coil-like, N-terminal re-
gion, supported by a hinge that props a bridge linking the
N-terminal region to the cell-interactive C-terminal foot region (8).
Experiments on supramolecular tropoelastin-based structures and
dynamic molecular models revealed a requirement for a subtle
balance between structure and flexibility within the molecule (25).
In this article we present the fully atomistic molecular struc-
ture of human tropoelastin, based on computationally intensive
MD simulations. We validated the structure against available
experimental molecular data. We then considered two alanine-
substitution mutations, R515A and D72A, within key regions of
the molecule. Arginine (R) 515 is a highly conserved residue that
stabilizes the tropoelastin bridge (26). Aspartate (D) 72 is the
sole negatively charged residue in the first half of tropoelastin
and functions to stabilize the N-terminal region (27). Mutations
at either site are associated with global conformational changes
and impaired functional assembly. We considered the molecular
geometry, secondary structure, and the location and exposure of
hydrophobic domains to explain observed differences in struc-
ture and hierarchical assembly. We created an elastic network
model based on the fully atomistic structure of the molecule to
predict the essential dynamics and explain differences in as-
sembly. We then introduced a mutation associated with acquired
cutis laxa to study the associated structural and dynamic changes.
Results
Fully Atomistic Model of Human Tropoelastin. The fully atomistic
model of tropoelastin was determined through a series of replica
exchange MD simulation stages (28) in implicit and explicit solvent
(Fig. 1A). The resulting ensemble of structures was clustered by
structural similarity based on rms deviation. A representative structure
of tropoelastin was identified by extracting the lowest energy structure
from the most populated cluster. This final structure, representative of
the most frequently occurring state within the ensemble, was com-
pared with predictions from small-angle X-ray scattering (SAXS)
based on work by Baldock et al. (8) (Fig. 1 B and C). Both models
displayed common features, characterized by a long molecular torso,
with two diverging branches toward the molecule’s bottom (the foot
region) linked by a bridge region, and with the N and C termini lo-
cated in their expected positions. Molecular dimensions correlated
closely between the atomistic model and the SAXS-derived structure
(Fig. 1D andE). No significant differences were seen in the narrowest
and widest horizontal lengths of the molecule, with a preserved gen-
eral envelope of the molecule. We found 6–9% α helix, 5% β sheet
and strand, 2% 310 and π helix, and 84–87% coil and turn structure in
simulation using the structure identification (STRIDE) algorithm.
Helices were counted for a minimum length of 7–10 consecutive
residues in helical formation, with a helix longevity >1 ns, based on
the observation that helical propensity is closely dependent on se-
quence length (29). Calculations were performed from a 50-ns pro-
duction run. Our findings are in close agreement with experimental
data that found 35–50% β sheet (including β turns), a small (10%)
contribution from α helices, and 40–55% unassigned to regular helices
or β structures (6). A detailed domain-by-domain comparison with
experimental data is included in SI Appendix.
Tropoelastin’s conserved global shape can be coarsely divided
into three main regions of interest: the elastic region extending
down from the N terminus, the foot region containing the cell-
interactive C terminus, and the bridge linking them, which has
been shown to play a key role in modulating fiber assembly (26).
To demonstrate how the fully atomistic model may be used to
assess the functionality of different regions within the molecule,
and to study disease etiology, we selected three residues of in-
terest: arginine 515 (R515), aspartate 72 (D72), and glycine 685
(G685). R515 is a highly conserved residue in mammalian tro-
poelastin that stabilizes the bridge region (26). D72 is the sole
negatively charged residue in the first half of tropoelastin and
functions to secure the N-terminal region (27). Finally, a muta-
tion of G685 to aspartate (G685D) is associated with acquired
cutis laxa, a disease characterized by pendulous inelastic skin and
inflammation in the vasculature (30), as well as early-onset
chronic obstructive pulmonary disease (31).
R515A Mutation. To evaluate the roles of R515 and D72, we
artificially mutated these residues into alanine (R515A and






Fig. 1. (A) Protein folding from a straight extended chain, through 2.3 μs of
total replica time, in implicit solvent, followed by 4.3 μs in explicit solvent. (B)
Front view and (C) back view of the representative structure of the tropoelastin
molecule. The atomistic model is shown in cartoon representation, with the α
helix in purple, the 310 helix in blue, the π helix in red, the extended β structure in
yellow, the β bridge in tan, the turn in cyan, and the coil in white. The SAXS
model is shown as a light-blue envelope. N and C indicate N and C termini, re-
spectively. Arrows show the narrowest and widest lengths. (D) The narrowest
length and (E) the widest horizontal length of tropoelastin in theMDmodel and
the averaged SAXS model. Error bars are based on the average of the last 50 ns
of the simulation. A 5% error bar is included for comparison in the SAXS model.































were inserted into the WT molecule and the structures were
equilibrated to convergence. The R515A mutant retained the
overall shape of the WT molecule, with the exception of a no-
ticeable shift in the foot, which displayed reduced extension (Fig. 2
A and B). The shift of the foot in the mutant may be explained by
a change in secondary structure that propagates into domains 26–
36 below the junction where residue 515 is located. An increased α
helix and β bridge content and decreased coil content between
WT and R515A were observed (Fig. 2C). A transformation to a
more-ordered secondary structure suggests that local secondary
structure changes in the bridge region may influence the flexibility
of the foot, resulting in a more compact shape. The analogous
dislocation of the mutant foot is visible in the SAXS structures,
which show confinement of this region to the body of the R515A
molecule (Fig. 2 D and E). Experimentally, the exposure of the
R515A C terminus, detected by an antibody specific for this re-
gion, was lower compared with WT (26), consistent with the
structural change observed in the molecular models (Fig. 2F).
The R515A mutation is also associated with a lower pro-
pensity for tropoelastin self-assembly (26). While both WT and
R515A displayed temperature-dependent coacervation, WT fully
coacervated at 35 °C, compared with 40 °C for R515A (Fig. 2G).
To understand these effects at the molecular scale, we measured
the solvent accessible surface area (SASA) of hydrophobic do-
mains in WT and R515A (Fig. 2H), since tropoelastin co-
acervation is primarily driven by hydrophobic interactions. SASA
is an indication of exposure and interactive potential with the
surrounding environment. R515A exhibited significantly less
exposed hydrophobic SASA than WT (Fig. 2H) as a consequence
of structural shifts in the molecule arising from the residue
substitution, which may help explain the difference in co-
acervation patterns observed in experiment (Fig. 2I).
Collective molecular motion may further direct self-assembly. To
examine this, we built elastic network models based on fully atomistic
structures, with α-carbons interconnected by uniform springs, and
calculated normal modes of motion. Low-frequency modes represent
the most concerted motions, where large structural subunits move
with respect to other subunits. These modes are most energetically
favorable on the multidimensional energy landscape and corre-
spond to intrinsically accessible motions within the molecule (32).
The current model supported our earlier description of WT
dynamics (25), represented by a characteristic twist in the
N-terminal region and a scissors-like motion about the bridge,
between the legs of the molecule (Fig. 2J and Movie S1). The
consistency between the current model and our earlier dynamic
model based on SAXS structures is instructive, as it shows the
strong dependency of normal modes on the global molecular
shape. Furthermore, the model is consistent with the observation
that dynamics driving coacervation may simultaneously preserve
intrinsic disorder, as has been suggested by recent NMR mea-
surements (33). The R515A mutant exhibited altered collective
dynamics (Fig. 2K and Movie S2), displaying a bend across the axis
perpendicular to the body of the molecule. The WT is more dy-
namic on the whole, showing higher rms fluctuation per residue
(Fig. 2L). We propose that the elevated level of mobility in the
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Fig. 2. (A, i) WT with R515 in red, circled; (ii) R515A mutant. (B) Extension of foot region for WT and R515A. (C) Secondary structure composition of WT and
R515A in domains 26–36 shows structural changes in β bridge, turn, and α helix content downstream of the mutation. (D, i) WT and (ii) R515A representative
structures from SAXS based on ref. 26. (E) Foot span indicated by dotted lines in the SAXS structures in D. (F) Percentage of C termini detected in WT and
R515A for different concentrations. (G) WT and R515A coacervation at different temperatures. (H) SASA of hydrophobic domains in WT and R515A. (Inset) WT
with hydrophobic SASA shown as a red envelope around the cyan molecular structure in cartoon representation. (I, i) Model of tropoelastin molecules in
purple secreted from the cell. (ii) Model of R515A self-assembly into sparser clusters, given a lower percentage of hydrophobic SASA. Molecules are indicated
by purple circles, where red represents hydrophobic SASA and dark blue represents water molecules surrounding protein. (iii) Model of WT self-assembly into
denser clusters, with a higher percentage of hydrophobic SASA. (J) WT and (K) R515A dynamic snapshots based on the linear combination of the first six
lowest-frequency modes. Eigenvectors per residue are shown as yellow arrows. (L) RMSF of residues in WT and R515A. The average was taken over last 50 ns
for B, C, and H. Data were modified from ref. 26 for F and G. RMSF, root-mean-square fluctuation.
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D72A Mutation. We performed a similar analysis on the D72A
mutant. D72A displayed a downward shift in the C-terminal re-
gion, leading to a restricted foot. This conformational change is
driven by a cascading shift in local secondary structure starting
from domain 6, and a twist in the upper N-terminal region (Fig. 3
A–C). Analogous shifts were observed in SAXS structures (Fig. 3
D and E). We predict the role of D72 in stabilizing the N-terminal
region of the molecule, as it is capable of forming salt bridges with
adjacent lysine (K) residues. In particular, D72 can interact with
K78 and K81 in domain 6 and, less likely, with K114 in domain 8
(Fig. 3F). A salt bridge develops between D72 and K78 or K81
21% and 30% of the time, respectively, and between D72A and
K114 2% of the time. Overall, D72 is involved in a salt
bridge >50% of the time, which would contribute significantly to
the stability of the N-terminal region. The absence of a prominent
salt bridge in D72A leaves the region to rotate freely into the
position at which it appears in the mutant. In D72A, the poly-
alanine region in domain 6 increases from four to six consecutive
alanines, resulting in an increase in α helix and hydrogen-bonded
turn content and a reduction in bend structure in domain 6. In-
creased helical content may lock into place the more flexible N-
terminal region, which is no longer held in place through a salt
bridge. The importance of D72 in stabilizing the molecule is fur-
ther emphasized in the observation that the conformational
changes associated with D72A propagate down the body of the
molecule, inducing a prominent foot displacement. The position
of domains 15 and 16, spanned by a long helical region below
domain 6, seems to be determined by steric exclusion. Based on
this observation, a shift in domain 6 may trigger global shape
changes by providing space for other regions to occupy. While WT
coacervated fully at 35 °C, D72A coacervated fully only at 40 °C
(Fig. 3G). Experimental findings are supported by SASA mea-
surements of hydrophobic residues in the WT and D72A models
(Fig. 3H). WT exhibited more exposed hydrophobic SASA than
D72A, which may contribute to the difference in coacervation
patterns. D72A also produced altered dynamics, displaying a
pronounced bending motion (Fig. 3I and Movie S3) and reduced
molecular fluctuation (Fig. 3J), consistent with experimental ob-
servations of reduced coacervation and impaired elastic fiber as-
sembly compared with WT (27).
G685D Acquired Cutis Laxa Mutation. We next considered a clini-
cally relevant mutation associated with acquired cutis laxa and
early-onset chronic obstructive pulmonary disease (30, 31). We
studied a tropoelastin isoform with a glycine-to-aspartate sub-
stitution in position 685 (G685D), derived from a mutation in
the ELN gene.
We found that the general molecular shape is preserved for
the mutant protein (Fig. 4A), although G685D has a bulkier,
displaced N-terminal region and an inwardly shifted, shortened
foot region (Fig. 4 A and B). G685D further stabilizes the salt
bridge between D72 and K78, which is present almost 100% of
the time. The shape change associated with the mutation intro-
duces two additional salt bridges, between glutamate 345 (E345)
and K356 (98% of the time) and between D685 and K647 (56%
of the time) (Fig. 4C). The salt bridges act to elongate and
tighten the molecule’s structure and are accompanied by a de-
crease in bend structure and a corresponding increase in α helix
content in domains 27–36 (Fig. 4D), effectively drawing the foot
in. The change in structure reduces the exposed hydrophobic
surface area as in R515A and D72A (Fig. 4E). We propose that
the altered molecular shape and reduced hydrophobic SASA
would result in changes in self-assembly of mutant tropoelastin,
as illustrated in the schematic in Fig. 4F. The dynamics of the
mutant molecule are also transformed, displaying a more pro-
nounced bending motion in contrast to the scissors-twist move-
ment of WT (Fig. 4 G and H and Movie S4). We find that
G685D has comparable residue-by-residue fluctuation as WT,
excluding domains 33 and 36 (the last 29 residues), where fluc-
tuation in G685D is reduced (Fig. 4H).
Discussion
Fully Atomistic Structure Prediction of the Tropoelastin Molecule.
The fully atomistic molecular structure of tropoelastin was suc-
cessfully predicted using a series of REMD simulations, and
validated against experimental data. Long-time REMD simula-
tions were essential to effectively sample a structure of the size of
the tropoelastin molecule. The need to conduct ergodic sampling
of the energy landscape stemmed from the observation that the
landscape for a system of the size and complexity of tropoelastin
would present local energy minima and encounter energy barriers
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Fig. 3. (A, i) WT with D72 in red, circled; (ii) D72A mutant. Arrows indicate domain shifts. (B) Extension of foot region for WT and D72A. (C) Secondary
structure composition of WT and D72A in domain 6 shows structural changes in bend, turn, and α helix content within the domain of the mutation. (D) WT (i)
and D72A (ii) representative structures from SAXS based on ref. 27. (E) Foot span of SAXS structures in D, as indicated by dotted lines. (F) WT with lysines 78,
81, and 114 in blue and aspartate 72 in red. (Inset) Close-up of lysine (K) and aspartate (D) residues that may be involved in salt bridges to stabilize the N-
terminal region. (G) WT and D72A coacervation at different temperatures. (H) SASA of hydrophobic domains in WT and D72A. (I) D72A dynamic snapshots
based on the linear combination of the first six lowest-frequency modes. Eigenvectors per residue are shown as yellow arrows. (J) RMSF of residues in WT and
D72A. The average was taken over 50 ns for B, C, and H. Data modified from ref. 27 for G. RMSF, root-mean-square fluctuation.































that would be difficult to cross at ambient temperatures within a
reasonable simulation time.
REMD resolved this problem by running a series of discrete,
independent replicas in varied temperature ensembles, where
coordinates of the replica structures were periodically exchanged
between ensembles. High-temperature replicas provided a means
to effectively cross energy barriers, while ambient-temperature
replicas presented an ensemble from which sampling is desired.
In each temperature ensemble, there was a distribution of struc-
tures with associated potential energies. Probability distributions
of potential energy were normally distributed. Adjacent temper-
ature ensembles were chosen so that there was sufficient overlap
in the probability distributions, implying that a particular structure
could exist in both. Metropolis-style Monte-Carlo moves were
constructed whereby coordinates of adjacent replicas could ex-
change based on the probability of being observed in both ensem-
bles. Improved ergodicity was achieved by ensuring the following
key considerations: (i) sufficient overlap, so that exchanges pro-
duce valid ensembles; (ii) adequately high temperatures to estab-
lish exhaustive ensemble space sampling; and (iii) high probability
of successful exchange attempts. In the first simulation stage, the
initial input structure was an extended linear chain built based on
the amino acid sequence of the tropoelastin molecule. The protein
folded progressively from a linearly extended initial conformation
to a compact final structure.
The representative structure from the initial phase was used as
an input for the second stage of REMD simulation in explicit
solvent. The role of water has been widely discussed for its
contributions to the unique mechanical properties and inverse
temperature transition capabilities of the elastin protein (19, 34–
36). Therefore, using an explicit solvent model was essential for
local structure refinement of the tropoelastin molecular model.
The similarity in the predicted fully atomistic model and the
SAXS-derived model is striking, identifying common features,
including a protruding foot region connected to a bridge (Fig. 1 B
and C), corresponding molecular dimensions (Fig. 1D and E), and
matching secondary structure distributions. We note that any local
inconsistency observed in the comparison between the SAXS
envelope and the fully atomistic structure in Fig. 1 B and C should
be expected, as the molecular structure embodies local and global
dynamic properties responsible for tropoelastin’s function and
assembly properties (25). Additional representative structures are
shown in SI Appendix, Fig. S15, to emphasize this point.
We observed that domain 2 and domain 36, the first and last
domains in the mature form of human tropoelastin, maintained
their expected locations at the head of the N-terminal region and
at the tip of the C-terminal foot region, respectively (SI Appendix,
Fig. S1). This positioning was consistent with earlier studies that
estimated these locations through structural comparisons of full-
length and truncated tropoelastin constructs using small-angle
X-ray and neutron scattering experiments (8). Domain 36, cor-
responding to the last 14 residues in the sequence, appeared to be
the most mobile of all tropoelastin domains based on rms fluc-
tuation (Figs. 2L, 3J, and 4H), consistent with its role in inter-
acting with cells (37, 38) and other elastic fiber proteins (39).
Mutation Studies. The model presents a lens through which to
study local structural impact and the influence on molecular
aggregation resulting from mutations in the protein structure.
We considered three mutations in this study: R515A and D72A,
corresponding to artificial mutations of arginine and aspartate to
alanine in positions 515 and 72, respectively, and G685D, a
glycine to aspartate substitution, associated with a clinically rel-
evant mutation found in patients with acquired cutis laxa and
early-onset chronic obstructive pulmonary disease (30, 31).
R515A and D72A mutations resulted in a local structural per-
turbation that drove changes in dynamics and coacervation be-
havior (Figs. 2 and 3). These studies not only expose the function
of important molecular regions but also provide a means of vali-
dating the model and a framework for studying other mutations.
In both the atomistic models and the SAXS-derived models of
R515A, the mutation yielded a compaction of the foot region,
which can be explained on the basis of the absence of a long,
charged side chain of arginine, and a transformation to a more
compact helical structure in the lower region of the mutant mol-
ecule. This change was further supported by an observed reduction
in the detection of the C terminus in antibody experiments. The
D72A mutation resulted in the perturbation of stabilizing salt
bridges and a cascading shift in secondary structure from the top
down, driving a twist at the N-terminal end of the molecule, and a
downward shift toward the molecular body at the C-terminal end.
The structural changes observed in response to both mutations
affected the coacervation, or self-assembly propensity, of the
mutants, in part driven by a reduction in solvent-exposed
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Fig. 4. (A, i) WT with G685 in red, circled; (ii) G685D mutant. (B) Extension of foot region for WT and G685D. (C) G685D with lysines 78, 356, and 647 in blue
and aspartate 72, glutamate 345, and aspartate 685 in red. (Inset) Close-up of lysine (K), aspartate (D), and glutamate (E) residues that may be involved in salt
bridges. (D) Secondary structure composition of WT and G685D in domains 27–36 shows structural changes in α helix and bend content. (E) SASA of hy-
drophobic domains in WT and G685D. (F, i) Model of WT self-assembly; (ii) model of G685D self-assembly (protein in purple, hydrophobic SASA in red, water
molecules in blue). (G) G685D dynamic snapshots based on the linear combination of the first six lowest-frequency modes. Eigenvectors per residue are shown
as yellow arrows. (H) RMSF of residues in WT and G685D. The average was taken over 50 ns for B, D, and E. RMSF, root-mean-square fluctuation.
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hydrophobic surface area. Dynamic models predicted a change
in the quality and magnitude of concerted molecular oscillation
contributing to differences in coacervation patterns.
A similar analysis was performed for the mutation G685D
(Fig. 4). The shortened foot identified for the mutant and re-
duced fluctuation in the C terminus of the mutant obscure the
exposure of the cell-interactive C-terminal region, explaining the
observed decrease in cell adhesion in the mutant (30). The in-
troduction of additional salt bridges throughout the molecule
contributes to changes in the mechanical properties of tropoe-
lastin. We propose that salt bridges can contribute to heightened
molecular stability and increased molecular stiffness, corre-
sponding to observations of coarser skin in patients with this
mutation (30). It is noted that the molecule’s inherent flexibility
results in significant changes throughout the entire molecular
structure in response to a single residue substitution, emphasiz-
ing the interplay of order and disorder within the molecule.
We propose that the shifted foot position, altered dynamics
within the foot region, an extended molecular shape supported by
salt bridges, and a reduction in exposed hydrophobic surface area
all play a role in hindering fiber assembly in acquired cutis laxa
and chronic obstructive pulmonary disease. This is supported by
experimental observation of a subtle defect in the deposition of
mutated tropoelastin into elastic fibers (30). We propose that the
structural characterization of this mutation is a first step to de-
veloping targeted therapies for this and related diseases.
To conclude, we have shown how accelerated-sampling MD
methods are used for ab initio folding of the 698-residue tro-
poelastin protein, a major flexible, elastic protein. We validated
the model against experimental data, used it as a template to
assess the function of local structural elements via artificial
mutations, and presented a structural study of a disease-associated
mutation. We identified structural shifts and variations in the
molecule’s dynamics in the presence of mutations, which may
explain differences seen in the molecular coacervation and as-
sembly patterns of mutants, and present mechanisms to elucidate
the molecular basis of disease not previously possible from ex-
periment alone. This work provides a framework to examine the
functional roles of particular tropoelastin domains, forms a
foundation for understanding the assembly of tropoelastin into
elastic fibers, and can be extended to study other disease muta-
tions. More generally, our approach would be suitable for probing
the structure and function of other highly disordered proteins.
Materials and Methods
The tropoelastin structure is computed from the primary protein structure of
mature, WT human tropoelastin corresponding to residues 27–724 of GenBank
entry AAC98394. The WT and mutant structures are simulated through a
series of replica exchange MD simulations. Structure dynamics are deter-
mined through elastic network models and normal mode analysis. Further
details can be found in SI Appendix.
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